Company Overview
Fidson Healthcare Plc is one of Nigeria’s leading indigenous manufacturers of pharmaceutical, focused on the production, marketing, and distribution of prescription medicines, over-the-counter (OTC) products, consumer healthcare products, and specialized pharmaceutical solutions. Founded in 1995 and headquartered in Lagos, the company has evolved into one of the largest local pharmaceutical manufacturers in the country.
Current price: N101.2
Rating: Buy
Price projection: N174.32 (+72.29%) and N222.12 (+119.45%)
Technical Analysis
In this report, we shall use the following tools and analysis methods:
Elliott’s wave theory to understand the overall market sentiment
Fibonacci tools to determine support and resistance levels
The Relative Strength Index and volume to evaluate the market’s strength
The Money Flow Index to determine the market liquidity
Moving average and MACD to understand the nature of the trend
Top-down analysis to know the best investment position
Elliott wave analysis
Weekly chart: Market overview
On the weekly chart, the stock finished an impulsive wave 3 and started a corrective wave 4. This position offers investors an opportunity to buy into value.
Daily chart: Investment Opportunity
Plotting the Fibonacci retracement from the beginning of wave 3 and 4, the investment opportunity lies within the 0.5 and 0.618 Fibonnaci levels. Thus, an early investment should lead to a short-term profit, which is wave B, and a long-term investment after wave C. The projections for this stock are N174.32 (+72.29%) and N222.12 (+119.45%)
Indicator analysis
Weekly chart: Market overview
On the weekly chart, the profit-taking commenced with a strong bearish volume. This performance makes Fidson a stock to watch. When the market bulls dominate, investors should look for the next investment opportunity. Overall, the market liquidity and momentum remain solid.
Daily chart: Investment opportunity
A notable signal on the daily time frame is the low liquidity and momentum. Despite these unfavorable conditions, market volume remained bullish, although low. Also, MACD’s bearish momentum sustained its divergence signal. Given Fidson’s good fundamentals, its price, liquidity, and momentum should increase.
Fundamental Analysis
Financial report for the year 2025
Key insight: The financial rating for Fidson is 89%, making it suitable for long-term investment
SWOT analysis
